2025;358:e2400564
(Accessed 27 January 2025 Crawford TO, Darras BT, Day JW, Dunaway Young S, Duong T, Nelson LL, Barrett D, Song G, Bilic, Cote SS (2024) safety and efficacy of apitegromab in patients with spinal muscular atrophy types 2 and 3: the phase 2 TOPAZ study
Stop the endless weight-loss cycle, and let us help you get to the best shape of your life
The significant superiority of professional individuals over non-professional individuals in both quality and engagement metrics highlights that expertise, when effectively communicated, is a key driver of reliable health communication (37, 38)
Transl Oncol 40:101856
Research peptides are sold for laboratory research purposes, not human consumption